Try our Advanced Search for more refined results

Mylan Fights Decision Blocking Generic Benicar

By Allison Grande ( August 19, 2009, 12:39 PM EDT) -- Mylan Pharmaceuticals Inc. is appealing a federal judge's decision to validate Daiichi Sankyo Co. Ltd.'s patent for the active ingredient in its hypertension drugs Benicar and Azor and to enjoin Mylan from producing the generic version of these drugs until the patent expires in April 2016....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!